Trial | NCT00492037  Report issue

Title

Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
A 5-Day, Double-Blind, Placebo-Controlled Multicenter Study of Oral YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    conivaptan ...

  • Study Participants

    83
Study of efficacy & safety of oral YM087 in subjects with euvolemic or hypervolemic hyponatremia
Study Started
Jan 31
2000
Study Completion
Feb 28
2002
Last Update
May 02
2014
Estimate

Drug YM087 oral

Criteria 

Inclusion Criteria:

Serum Sodium 115 to <130mEq/L
Plasma Osmolarity <290 mOsmol/kg H2O

Exclusion Criteria:

Significant renal insufficiency
Serum sodium increase of ≥8 mEq/L over the baseline day ( Hours 0 to 12)
No Results Posted